The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Third-Generation Sequencing Technology Market Expected To Scale Between 2026 And 2030?
The third-generation sequencing technology market size has seen rapid expansion in recent years. It is forecast to grow from $14 billion in 2025 to $15.96 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.0%. Key drivers for this historical growth include genomics research funding, the constraints of short-read sequencing, increased academic research adoption, a rise in rare disease studies, and ongoing technology innovation.
The third-generation sequencing technology market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $26.71 billion, demonstrating a compound annual growth rate (CAGR) of 13.7%. Factors driving this growth during the projected period include the broadening scope of precision medicine, increased uptake of clinical diagnostics, a decrease in sequencing expenditures, the incorporation of AI analytics, and various population genomics programs. Key developments expected throughout this forecast period encompass advancements such as long-read sequencing technologies, real-time DNA sequencing capabilities, the wider implementation of clinical genomics, single-molecule sequencing methods, and the emergence of portable sequencing platforms.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Third-Generation Sequencing Technology Market Landscape?
The growing acceptance of personalized medicine is anticipated to fuel the expansion of the third-generation sequencing technology market. This medical approach customizes treatment and prevention plans based on an individual’s distinct genetic profile, lifestyle, and environmental factors. The rising adoption of personalized medicine is largely attributed to progress in genomics, which allows for accurate detection of genetic variations and customized therapies for patients. Third-generation sequencing technology improves personalized medicine by offering long-read, high-accuracy genomic data, thereby enabling precise identification of genetic variations. It facilitates personalized treatment plans through thorough insights into individual genomes, leading to better clinical results and advancements in precision healthcare. For illustration, in February 2024, the U.S. Food and Drug Administration (FDA) endorsed 26 new personalized medicines in 2023, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization. This represents a substantial increase from the 12 approved in 2022. Consequently, the increasing embrace of personalized medicine is stimulating the growth of the third-generation sequencing technology market.
How Is Segmentation Applied In The Third-Generation Sequencing Technology Market Segment Analysis?
The third-generation sequencing technology market covered in this report is segmented –
1) By Technology Type: Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing
2) By Workflow: Sample Preparation, Sequencing, Data Analysis, Data Interpretation, Data Storage And Management
3) By Application: Genomics, Transcriptomics, Epigenomics, Metagenomics, Personalized Medicine, Synthetic Biology
4) By End-User: Academic Institutions, Clinical Laboratories, Pharmaceutical And Biotechnology Companies, Research Organizations, Government And Non-Profit Organizations
Subsegments:
1) By Single-Molecule Real-Time Sequencing (SMRT): Zero-Mode Waveguides (ZMWs), Circular Consensus Sequencing (CCS), High-Fidelity (HiFi) Reads
2) By Nanopore Sequencing: Portable Nanopore Sequencers, Benchtop Nanopore Sequencers, High-Throughput Nanopore Platforms
What Market Trends Are Affecting The Third-Generation Sequencing Technology Market?
Leading companies in the third-generation sequencing technology market are concentrating on developing advanced sequencing platforms, such as ultra-rapid and scalable sequencing systems, to enhance research efficiency, improve clinical applicability, and reduce both turnaround times and costs. These ultra-rapid and scalable sequencing systems refer to innovative technologies that facilitate high-throughput, real-time genomic analysis with exceptional speed and accuracy, enabling comprehensive genomic profiling across various applications. For instance, in February 2025, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced its Sequencing by Expansion (SBX) technology. This fully integrated, next-generation sequencing system features a patented biochemical process that converts DNA or RNA sequences into measurable surrogate polymers called Xpandomers, enabling highly accurate single-molecule nanopore sequencing. The SBX platform includes ultra-rapid, scalable sequencing capabilities and automated data analysis, delivering whole-genome sequencing results in hours rather than days without extensive manual intervention.
Who Are The Companies Participating In The Third-Generation Sequencing Technology Market Environment?
Major companies operating in the third-generation sequencing technology market are Oxford Nanopore Technologies, Pacific Biosciences, Quantapore, Ultima Genomics, BGI Genomics, MGI Tech, Complete Genomics, Stratos Genomics, VisiGen Biotechnologies, Helicos Biosciences, Genia Technologies, Electronic Bio Sciences, Quantum Biosystems, Base4 Innovation, Nabsys, Chronix Biomedical, Roche, Nanopore Diagnostics, GenapSys, SomaLogic
Get The Full Third-Generation Sequencing Technology Market Report:
Which Region Is The Largest In The Third-Generation Sequencing Technology Market?
North America was the largest region in the third-generation sequencing technology market in 2025. The regions covered in the third-generation sequencing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Third-Generation Sequencing Technology Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Third-Generation Sequencing Technology Market 2026, By The Business Research Company
Clinical Oncology Next Generation Sequencing Market Report 2026
Dna Sequencing Market Report 2026
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Clinical Next Generation Sequencing Ngs Data Analysis Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model